 Tor Wager
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain | 72 | 2023 | 736 | 17.100 |
Why?
| | Brain | 129 | 2023 | 2481 | 16.920 |
Why?
| | Brain Mapping | 91 | 2023 | 530 | 14.040 |
Why?
| | Magnetic Resonance Imaging | 132 | 2023 | 3169 | 9.640 |
Why?
| | Emotions | 38 | 2023 | 494 | 8.270 |
Why?
| | Pain Perception | 18 | 2020 | 36 | 8.220 |
Why?
| | Placebo Effect | 29 | 2021 | 52 | 7.750 |
Why?
| | Neuroimaging | 26 | 2021 | 256 | 4.910 |
Why?
| | Prefrontal Cortex | 27 | 2023 | 275 | 4.740 |
Why?
| | Analgesia | 13 | 2021 | 81 | 4.720 |
Why?
| | Pain Measurement | 24 | 2023 | 468 | 4.460 |
Why?
| | Chronic Pain | 14 | 2023 | 211 | 4.430 |
Why?
| | Image Processing, Computer-Assisted | 29 | 2022 | 709 | 4.190 |
Why?
| | Neural Pathways | 21 | 2021 | 277 | 3.870 |
Why?
| | Nerve Net | 23 | 2021 | 232 | 3.750 |
Why?
| | Pain Management | 13 | 2023 | 293 | 3.540 |
Why?
| | Nociception | 9 | 2021 | 17 | 3.120 |
Why?
| | Affect | 12 | 2023 | 238 | 3.030 |
Why?
| | Empathy | 10 | 2021 | 142 | 2.910 |
Why?
| | Models, Neurological | 12 | 2021 | 216 | 2.810 |
Why?
| | Memory, Short-Term | 11 | 2022 | 232 | 2.780 |
Why?
| | Cognition | 22 | 2022 | 1026 | 2.730 |
Why?
| | Learning | 11 | 2022 | 373 | 2.700 |
Why?
| | Social Behavior | 8 | 2019 | 275 | 2.680 |
Why?
| | Interpersonal Relations | 7 | 2020 | 342 | 2.660 |
Why?
| | Functional Neuroimaging | 19 | 2022 | 67 | 2.580 |
Why?
| | Galvanic Skin Response | 9 | 2021 | 28 | 2.420 |
Why?
| | Humans | 253 | 2023 | 118257 | 2.370 |
Why?
| | Young Adult | 73 | 2021 | 10731 | 2.340 |
Why?
| | Cerebral Cortex | 20 | 2022 | 415 | 2.280 |
Why?
| | Meditation | 6 | 2022 | 34 | 2.230 |
Why?
| | Pain Threshold | 9 | 2022 | 69 | 2.160 |
Why?
| | Attention | 13 | 2014 | 407 | 2.130 |
Why?
| | Periaqueductal Gray | 6 | 2021 | 15 | 2.110 |
Why?
| | Adult | 105 | 2023 | 31325 | 2.090 |
Why?
| | Machine Learning | 9 | 2022 | 321 | 2.000 |
Why?
| | Back Pain | 4 | 2023 | 44 | 1.820 |
Why?
| | Cues | 11 | 2022 | 297 | 1.820 |
Why?
| | Heart Rate | 5 | 2019 | 729 | 1.810 |
Why?
| | Stress, Psychological | 11 | 2022 | 967 | 1.780 |
Why?
| | Male | 124 | 2023 | 57476 | 1.770 |
Why?
| | Amygdala | 10 | 2021 | 175 | 1.770 |
Why?
| | Female | 126 | 2023 | 61262 | 1.750 |
Why?
| | Fear | 13 | 2022 | 306 | 1.730 |
Why?
| | Image Interpretation, Computer-Assisted | 11 | 2020 | 220 | 1.660 |
Why?
| | Hot Temperature | 12 | 2022 | 333 | 1.630 |
Why?
| | Gyrus Cinguli | 9 | 2020 | 68 | 1.590 |
Why?
| | Social Perception | 4 | 2021 | 98 | 1.560 |
Why?
| | Fibromyalgia | 6 | 2023 | 56 | 1.560 |
Why?
| | Mindfulness | 3 | 2022 | 94 | 1.520 |
Why?
| | Touch | 3 | 2020 | 32 | 1.500 |
Why?
| | Conditioning, Classical | 5 | 2022 | 89 | 1.470 |
Why?
| | Anticipation, Psychological | 4 | 2019 | 17 | 1.450 |
Why?
| | Trust | 3 | 2023 | 113 | 1.270 |
Why?
| | Functional Laterality | 5 | 2019 | 208 | 1.180 |
Why?
| | Frontal Lobe | 7 | 2018 | 147 | 1.180 |
Why?
| | Phobia, Social | 3 | 2023 | 14 | 1.170 |
Why?
| | Physician-Patient Relations | 4 | 2023 | 484 | 1.160 |
Why?
| | Association Learning | 2 | 2017 | 59 | 1.120 |
Why?
| | Analgesics, Opioid | 7 | 2020 | 789 | 1.110 |
Why?
| | Artifacts | 7 | 2021 | 125 | 1.100 |
Why?
| | Reward | 10 | 2023 | 209 | 1.070 |
Why?
| | Low Back Pain | 3 | 2023 | 100 | 1.070 |
Why?
| | Physical Stimulation | 10 | 2019 | 79 | 1.020 |
Why?
| | Mental Processes | 4 | 2016 | 35 | 1.010 |
Why?
| | Biomarkers | 10 | 2023 | 3568 | 1.010 |
Why?
| | Individuality | 8 | 2021 | 148 | 0.990 |
Why?
| | Corpus Striatum | 3 | 2019 | 127 | 0.990 |
Why?
| | Neurosciences | 3 | 2015 | 22 | 0.970 |
Why?
| | Reproducibility of Results | 14 | 2023 | 2855 | 0.960 |
Why?
| | Visual Cortex | 2 | 2019 | 40 | 0.950 |
Why?
| | Meta-Analysis as Topic | 7 | 2018 | 164 | 0.940 |
Why?
| | Self-Control | 3 | 2019 | 49 | 0.930 |
Why?
| | Irritable Bowel Syndrome | 3 | 2023 | 29 | 0.930 |
Why?
| | Culture | 3 | 2020 | 127 | 0.930 |
Why?
| | Fraud | 1 | 2023 | 7 | 0.910 |
Why?
| | Nocebo Effect | 5 | 2021 | 9 | 0.900 |
Why?
| | Adolescent | 38 | 2021 | 18364 | 0.900 |
Why?
| | Psychomotor Performance | 12 | 2021 | 289 | 0.890 |
Why?
| | Placebos | 8 | 2021 | 202 | 0.890 |
Why?
| | Algorithms | 10 | 2022 | 1522 | 0.890 |
Why?
| | Social Learning | 2 | 2023 | 6 | 0.860 |
Why?
| | Middle Aged | 39 | 2022 | 27511 | 0.850 |
Why?
| | Models, Statistical | 8 | 2018 | 633 | 0.840 |
Why?
| | Problem Solving | 1 | 2023 | 145 | 0.830 |
Why?
| | Behavior | 5 | 2021 | 94 | 0.820 |
Why?
| | Pulvinar | 1 | 2021 | 4 | 0.810 |
Why?
| | Neurons | 3 | 2020 | 1340 | 0.810 |
Why?
| | Semantics | 2 | 2021 | 90 | 0.790 |
Why?
| | Ego | 1 | 2021 | 10 | 0.790 |
Why?
| | Nociceptive Pain | 1 | 2020 | 1 | 0.780 |
Why?
| | Superior Colliculi | 1 | 2021 | 33 | 0.780 |
Why?
| | Extinction, Psychological | 4 | 2016 | 81 | 0.780 |
Why?
| | Oxygen | 10 | 2018 | 854 | 0.770 |
Why?
| | Shoulder Pain | 1 | 2021 | 38 | 0.770 |
Why?
| | Stereotyping | 1 | 2021 | 37 | 0.770 |
Why?
| | Depressive Disorder, Major | 6 | 2023 | 302 | 0.760 |
Why?
| | Sexism | 1 | 2021 | 45 | 0.760 |
Why?
| | Sexual Partners | 2 | 2019 | 158 | 0.750 |
Why?
| | Photic Stimulation | 13 | 2021 | 204 | 0.750 |
Why?
| | Guilt | 1 | 2020 | 11 | 0.750 |
Why?
| | Psychophysiology | 4 | 2011 | 17 | 0.740 |
Why?
| | Consensus | 4 | 2021 | 533 | 0.730 |
Why?
| | Motivation | 8 | 2023 | 502 | 0.730 |
Why?
| | Computer Simulation | 10 | 2019 | 913 | 0.730 |
Why?
| | Nucleus Accumbens | 3 | 2017 | 131 | 0.720 |
Why?
| | Movement | 2 | 2020 | 248 | 0.720 |
Why?
| | Biomedical Technology | 1 | 2020 | 43 | 0.720 |
Why?
| | Mental Recall | 3 | 2016 | 180 | 0.710 |
Why?
| | Arousal | 6 | 2021 | 156 | 0.680 |
Why?
| | Visual Perception | 5 | 2021 | 141 | 0.670 |
Why?
| | Models, Psychological | 3 | 2017 | 298 | 0.650 |
Why?
| | Diagnostic Imaging | 8 | 2010 | 294 | 0.650 |
Why?
| | Reaction Time | 11 | 2019 | 390 | 0.640 |
Why?
| | Pattern Recognition, Automated | 2 | 2015 | 75 | 0.640 |
Why?
| | Neuralgia | 1 | 2020 | 120 | 0.640 |
Why?
| | Mental Disorders | 4 | 2022 | 935 | 0.640 |
Why?
| | Nonlinear Dynamics | 4 | 2017 | 88 | 0.630 |
Why?
| | Language | 2 | 2017 | 271 | 0.630 |
Why?
| | Piperidines | 3 | 2013 | 171 | 0.620 |
Why?
| | Healthy Volunteers | 7 | 2022 | 194 | 0.620 |
Why?
| | Suggestion | 1 | 2017 | 5 | 0.600 |
Why?
| | Pattern Recognition, Physiological | 1 | 2017 | 2 | 0.600 |
Why?
| | Brain Stem | 2 | 2018 | 104 | 0.600 |
Why?
| | Evoked Potentials | 3 | 2007 | 115 | 0.590 |
Why?
| | Social Support | 1 | 2020 | 527 | 0.590 |
Why?
| | Somatosensory Cortex | 3 | 2019 | 37 | 0.580 |
Why?
| | Anxiety | 7 | 2021 | 845 | 0.570 |
Why?
| | Depressive Disorder | 2 | 2017 | 333 | 0.560 |
Why?
| | Helping Behavior | 1 | 2016 | 15 | 0.560 |
Why?
| | Family Characteristics | 1 | 2017 | 155 | 0.550 |
Why?
| | Stress, Physiological | 2 | 2016 | 414 | 0.550 |
Why?
| | Health Status | 1 | 2021 | 723 | 0.540 |
Why?
| | Stress Disorders, Post-Traumatic | 7 | 2019 | 760 | 0.540 |
Why?
| | Mental Health | 1 | 2021 | 567 | 0.530 |
Why?
| | Research | 1 | 2018 | 406 | 0.520 |
Why?
| | Forecasting | 2 | 2015 | 348 | 0.510 |
Why?
| | Executive Function | 6 | 2022 | 390 | 0.510 |
Why?
| | Connectome | 6 | 2022 | 63 | 0.510 |
Why?
| | Social Discrimination | 1 | 2014 | 11 | 0.490 |
Why?
| | Abdominal Pain | 1 | 2015 | 133 | 0.490 |
Why?
| | Tomography, Emission-Computed | 5 | 2004 | 58 | 0.480 |
Why?
| | Autonomic Nervous System | 5 | 2021 | 66 | 0.480 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 56 | 0.470 |
Why?
| | Motor Cortex | 3 | 2017 | 52 | 0.460 |
Why?
| | Positron-Emission Tomography | 4 | 2015 | 298 | 0.460 |
Why?
| | Citalopram | 3 | 2019 | 27 | 0.460 |
Why?
| | Pleasure | 1 | 2013 | 18 | 0.450 |
Why?
| | Hemodynamics | 4 | 2013 | 1002 | 0.450 |
Why?
| | Bayes Theorem | 3 | 2023 | 341 | 0.440 |
Why?
| | Central Nervous System | 1 | 2015 | 243 | 0.440 |
Why?
| | Perception | 2 | 2017 | 314 | 0.440 |
Why?
| | Negotiating | 1 | 2012 | 25 | 0.430 |
Why?
| | Imagination | 2 | 2018 | 15 | 0.430 |
Why?
| | Models, Theoretical | 3 | 2019 | 554 | 0.430 |
Why?
| | Minority Groups | 1 | 2014 | 236 | 0.430 |
Why?
| | Depression | 2 | 2019 | 1133 | 0.420 |
Why?
| | Memory, Long-Term | 1 | 2012 | 11 | 0.420 |
Why?
| | Haplorhini | 1 | 2012 | 62 | 0.420 |
Why?
| | Artificial Intelligence | 1 | 2013 | 137 | 0.410 |
Why?
| | Analgesics | 4 | 2020 | 159 | 0.410 |
Why?
| | Social Desirability | 1 | 2011 | 14 | 0.400 |
Why?
| | Video Recording | 3 | 2021 | 154 | 0.400 |
Why?
| | Antidepressive Agents | 4 | 2019 | 190 | 0.400 |
Why?
| | Brain Chemistry | 2 | 2012 | 118 | 0.400 |
Why?
| | Mood Disorders | 1 | 2012 | 119 | 0.390 |
Why?
| | Software | 3 | 2014 | 566 | 0.390 |
Why?
| | Endothelial Cells | 1 | 2016 | 717 | 0.380 |
Why?
| | Sensitivity and Specificity | 7 | 2021 | 1787 | 0.380 |
Why?
| | Natural Language Processing | 1 | 2011 | 71 | 0.380 |
Why?
| | Acute Pain | 2 | 2023 | 33 | 0.370 |
Why?
| | Touch Perception | 2 | 2020 | 10 | 0.370 |
Why?
| | Linear Models | 6 | 2017 | 817 | 0.370 |
Why?
| | Data Mining | 1 | 2011 | 100 | 0.370 |
Why?
| | Feedback, Psychological | 3 | 2017 | 20 | 0.360 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1433 | 0.350 |
Why?
| | Neuropsychological Tests | 9 | 2018 | 1027 | 0.350 |
Why?
| | Regression Analysis | 4 | 2015 | 984 | 0.340 |
Why?
| | Self Concept | 4 | 2023 | 213 | 0.340 |
Why?
| | Cerebrovascular Circulation | 2 | 2008 | 203 | 0.340 |
Why?
| | Periodicals as Topic | 1 | 2011 | 187 | 0.330 |
Why?
| | Concept Formation | 1 | 2008 | 25 | 0.330 |
Why?
| | Image Enhancement | 3 | 2021 | 181 | 0.330 |
Why?
| | Sex Characteristics | 3 | 2014 | 667 | 0.310 |
Why?
| | Statistics as Topic | 4 | 2017 | 307 | 0.310 |
Why?
| | Multivariate Analysis | 4 | 2020 | 1469 | 0.310 |
Why?
| | Medicine | 1 | 2009 | 106 | 0.300 |
Why?
| | Receptors, Opioid, mu | 1 | 2007 | 52 | 0.300 |
Why?
| | Animals | 15 | 2021 | 33152 | 0.300 |
Why?
| | Implosive Therapy | 2 | 2018 | 36 | 0.300 |
Why?
| | Signal Processing, Computer-Assisted | 4 | 2014 | 140 | 0.290 |
Why?
| | Nociceptors | 1 | 2006 | 15 | 0.280 |
Why?
| | Decision Making | 4 | 2022 | 806 | 0.280 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2006 | 33 | 0.280 |
Why?
| | Mind-Body Relations, Metaphysical | 1 | 2005 | 1 | 0.270 |
Why?
| | Weather | 1 | 2005 | 24 | 0.270 |
Why?
| | Mesencephalon | 4 | 2020 | 57 | 0.270 |
Why?
| | Classification | 1 | 2005 | 23 | 0.260 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 73 | 0.260 |
Why?
| | Facial Expression | 3 | 2019 | 62 | 0.250 |
Why?
| | Judgment | 3 | 2011 | 59 | 0.230 |
Why?
| | False Positive Reactions | 3 | 2019 | 115 | 0.220 |
Why?
| | Anxiety Disorders | 2 | 2021 | 310 | 0.220 |
Why?
| | Gambling | 1 | 2023 | 31 | 0.220 |
Why?
| | Comprehension | 2 | 2018 | 162 | 0.220 |
Why?
| | Odorants | 1 | 2023 | 137 | 0.220 |
Why?
| | Support Vector Machine | 1 | 2022 | 36 | 0.220 |
Why?
| | Drug Users | 1 | 2022 | 39 | 0.220 |
Why?
| | Politics | 1 | 2023 | 80 | 0.210 |
Why?
| | Nervous System | 2 | 2021 | 64 | 0.210 |
Why?
| | Self Report | 3 | 2020 | 698 | 0.210 |
Why?
| | Disability Evaluation | 2 | 2022 | 278 | 0.210 |
Why?
| | Biological Variation, Population | 1 | 2021 | 21 | 0.210 |
Why?
| | Hypothalamus, Posterior | 1 | 2021 | 4 | 0.210 |
Why?
| | Antibodies, Neoplasm | 1 | 2021 | 30 | 0.210 |
Why?
| | Attitude to Health | 1 | 2005 | 410 | 0.200 |
Why?
| | Escape Reaction | 1 | 2021 | 68 | 0.200 |
Why?
| | Treatment Outcome | 8 | 2022 | 9319 | 0.200 |
Why?
| | Motion Pictures | 1 | 2021 | 13 | 0.200 |
Why?
| | Visceral Pain | 1 | 2020 | 1 | 0.200 |
Why?
| | Case-Control Studies | 6 | 2018 | 3156 | 0.200 |
Why?
| | Gray Matter | 2 | 2018 | 66 | 0.200 |
Why?
| | Psychology | 2 | 2020 | 84 | 0.190 |
Why?
| | Substance-Related Disorders | 2 | 2022 | 967 | 0.190 |
Why?
| | Cluster Analysis | 2 | 2014 | 479 | 0.190 |
Why?
| | Imitative Behavior | 1 | 2020 | 7 | 0.190 |
Why?
| | Data Interpretation, Statistical | 2 | 2014 | 334 | 0.190 |
Why?
| | Switzerland | 1 | 2020 | 27 | 0.190 |
Why?
| | Phagocytes | 1 | 2020 | 90 | 0.180 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2020 | 110 | 0.180 |
Why?
| | Sensory Thresholds | 2 | 2017 | 30 | 0.180 |
Why?
| | Cross-Cultural Comparison | 1 | 2020 | 81 | 0.180 |
Why?
| | Manipulation, Spinal | 1 | 2019 | 8 | 0.180 |
Why?
| | Neck Pain | 1 | 2019 | 24 | 0.180 |
Why?
| | China | 1 | 2020 | 175 | 0.180 |
Why?
| | Choice Behavior | 2 | 2011 | 160 | 0.180 |
Why?
| | Thoracic Vertebrae | 1 | 2019 | 72 | 0.170 |
Why?
| | Head Movements | 1 | 2019 | 18 | 0.170 |
Why?
| | Neurofeedback | 1 | 2018 | 2 | 0.170 |
Why?
| | Schizophrenia | 2 | 2014 | 501 | 0.170 |
Why?
| | Reading | 2 | 2014 | 156 | 0.170 |
Why?
| | Social Control, Formal | 1 | 2018 | 10 | 0.170 |
Why?
| | Bias | 3 | 2017 | 197 | 0.170 |
Why?
| | Electrocardiography | 2 | 2019 | 555 | 0.170 |
Why?
| | Personality | 1 | 2020 | 115 | 0.170 |
Why?
| | Auditory Cortex | 1 | 2018 | 41 | 0.170 |
Why?
| | Facial Recognition | 1 | 2019 | 28 | 0.160 |
Why?
| | Recidivism | 1 | 2018 | 4 | 0.160 |
Why?
| | Rest | 2 | 2017 | 104 | 0.160 |
Why?
| | Adiposity | 1 | 2023 | 508 | 0.160 |
Why?
| | Acceptance and Commitment Therapy | 1 | 2018 | 28 | 0.160 |
Why?
| | Genomics | 1 | 2023 | 668 | 0.160 |
Why?
| | Time Factors | 6 | 2021 | 6368 | 0.160 |
Why?
| | Behavior, Animal | 1 | 2021 | 486 | 0.160 |
Why?
| | Psychological Theory | 1 | 2018 | 94 | 0.160 |
Why?
| | Criminals | 1 | 2018 | 31 | 0.160 |
Why?
| | Racism | 1 | 2020 | 102 | 0.160 |
Why?
| | Lymph Nodes | 1 | 2020 | 443 | 0.160 |
Why?
| | White Matter | 1 | 2019 | 115 | 0.160 |
Why?
| | Cardiovascular System | 2 | 2017 | 127 | 0.160 |
Why?
| | Attitude | 1 | 2019 | 230 | 0.160 |
Why?
| | Consciousness | 1 | 2017 | 21 | 0.150 |
Why?
| | Spatial Regression | 1 | 2017 | 1 | 0.150 |
Why?
| | Neural Inhibition | 2 | 2017 | 160 | 0.150 |
Why?
| | Adolescent Development | 1 | 2018 | 84 | 0.150 |
Why?
| | Cognitive Neuroscience | 1 | 2017 | 10 | 0.150 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2017 | 12 | 0.150 |
Why?
| | Acoustic Stimulation | 2 | 2018 | 321 | 0.150 |
Why?
| | Antisocial Personality Disorder | 1 | 2018 | 160 | 0.150 |
Why?
| | Wakefulness | 1 | 2018 | 128 | 0.150 |
Why?
| | Theory of Mind | 2 | 2017 | 9 | 0.150 |
Why?
| | Models, Animal | 1 | 2018 | 349 | 0.150 |
Why?
| | Markov Chains | 2 | 2014 | 118 | 0.150 |
Why?
| | Prejudice | 1 | 2017 | 56 | 0.140 |
Why?
| | Sleep Deprivation | 1 | 2019 | 164 | 0.140 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 1857 | 0.140 |
Why?
| | Schizophrenic Psychology | 2 | 2014 | 113 | 0.140 |
Why?
| | Charities | 1 | 2016 | 9 | 0.140 |
Why?
| | Proof of Concept Study | 1 | 2016 | 46 | 0.140 |
Why?
| | B-Lymphocytes | 1 | 2021 | 767 | 0.140 |
Why?
| | E-Selectin | 1 | 2016 | 51 | 0.140 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1318 | 0.140 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1379 | 0.140 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 193 | 0.140 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2016 | 55 | 0.140 |
Why?
| | Resilience, Psychological | 1 | 2017 | 97 | 0.140 |
Why?
| | Task Performance and Analysis | 2 | 2014 | 164 | 0.140 |
Why?
| | Species Specificity | 2 | 2020 | 559 | 0.140 |
Why?
| | Child Development | 1 | 2020 | 402 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2021 | 744 | 0.130 |
Why?
| | Guidelines as Topic | 1 | 2017 | 261 | 0.130 |
Why?
| | Sertraline | 1 | 2015 | 26 | 0.130 |
Why?
| | Respiratory Sinus Arrhythmia | 1 | 2015 | 12 | 0.130 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2015 | 28 | 0.130 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 59 | 0.130 |
Why?
| | Parietal Lobe | 1 | 2015 | 42 | 0.130 |
Why?
| | Ventral Striatum | 1 | 2015 | 8 | 0.130 |
Why?
| | Vagus Nerve | 1 | 2015 | 80 | 0.130 |
Why?
| | Thalamus | 3 | 2019 | 80 | 0.130 |
Why?
| | Dominance, Cerebral | 2 | 2005 | 52 | 0.130 |
Why?
| | Afferent Pathways | 1 | 2014 | 44 | 0.120 |
Why?
| | Thinking | 1 | 2014 | 54 | 0.120 |
Why?
| | Psychotherapy | 1 | 2016 | 177 | 0.120 |
Why?
| | Normal Distribution | 1 | 2014 | 24 | 0.120 |
Why?
| | Cognition Disorders | 1 | 2018 | 528 | 0.120 |
Why?
| | Respiratory Rate | 1 | 2013 | 18 | 0.120 |
Why?
| | Sex Factors | 1 | 2019 | 1765 | 0.120 |
Why?
| | Hippocampus | 1 | 2018 | 735 | 0.120 |
Why?
| | Reference Values | 2 | 2006 | 770 | 0.120 |
Why?
| | Signal-To-Noise Ratio | 1 | 2014 | 59 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1590 | 0.120 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2013 | 13 | 0.120 |
Why?
| | Speech | 2 | 2017 | 75 | 0.120 |
Why?
| | Pattern Recognition, Visual | 2 | 2004 | 88 | 0.110 |
Why?
| | Anger | 1 | 2013 | 59 | 0.110 |
Why?
| | Arm | 1 | 2014 | 106 | 0.110 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 4684 | 0.110 |
Why?
| | Craving | 2 | 2023 | 33 | 0.110 |
Why?
| | Flow Cytometry | 1 | 2016 | 1072 | 0.110 |
Why?
| | Sleep | 1 | 2018 | 651 | 0.110 |
Why?
| | Skin | 1 | 2017 | 657 | 0.110 |
Why?
| | Parkinson Disease | 2 | 2014 | 334 | 0.110 |
Why?
| | Electric Stimulation | 3 | 2020 | 268 | 0.100 |
Why?
| | Risk-Taking | 1 | 2015 | 318 | 0.100 |
Why?
| | Injections, Intravenous | 1 | 2012 | 209 | 0.100 |
Why?
| | Antipsychotic Agents | 1 | 2014 | 192 | 0.100 |
Why?
| | Logistic Models | 1 | 2017 | 1896 | 0.100 |
Why?
| | ROC Curve | 1 | 2013 | 470 | 0.100 |
Why?
| | Survivors | 1 | 2014 | 411 | 0.100 |
Why?
| | Life Change Events | 2 | 2014 | 132 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 1937 | 0.100 |
Why?
| | Polymorphism, Genetic | 1 | 2014 | 641 | 0.100 |
Why?
| | Hyperalgesia | 1 | 2012 | 108 | 0.100 |
Why?
| | Disease Progression | 1 | 2018 | 2477 | 0.100 |
Why?
| | Aged | 5 | 2020 | 19594 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2434 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1656 | 0.090 |
Why?
| | Signal Detection, Psychological | 1 | 2010 | 21 | 0.090 |
Why?
| | Stroop Test | 2 | 2020 | 26 | 0.090 |
Why?
| | Psychosomatic Medicine | 1 | 2009 | 1 | 0.090 |
Why?
| | United States | 2 | 2023 | 12491 | 0.090 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2009 | 41 | 0.090 |
Why?
| | Genotype | 1 | 2014 | 1870 | 0.090 |
Why?
| | Somatoform Disorders | 1 | 2009 | 38 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2016 | 499 | 0.080 |
Why?
| | Neuroanatomy | 1 | 2008 | 12 | 0.080 |
Why?
| | Child | 4 | 2020 | 19033 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2057 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2013 | 1237 | 0.080 |
Why?
| | Lung | 1 | 2020 | 3623 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2010 | 401 | 0.080 |
Why?
| | Dendritic Cells | 2 | 2021 | 442 | 0.080 |
Why?
| | Phobic Disorders | 1 | 2007 | 27 | 0.080 |
Why?
| | Carbon Radioisotopes | 1 | 2007 | 45 | 0.080 |
Why?
| | Inflammation | 1 | 2018 | 2545 | 0.080 |
Why?
| | Limbic System | 1 | 2007 | 42 | 0.080 |
Why?
| | Data Collection | 1 | 2010 | 652 | 0.080 |
Why?
| | Field Dependence-Independence | 1 | 2007 | 3 | 0.080 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 4887 | 0.080 |
Why?
| | Databases, Factual | 3 | 2020 | 1196 | 0.080 |
Why?
| | Space Perception | 2 | 2007 | 65 | 0.080 |
Why?
| | Research Design | 3 | 2017 | 961 | 0.070 |
Why?
| | Perceptual Masking | 1 | 2007 | 15 | 0.070 |
Why?
| | Cerebral Arteries | 1 | 2007 | 56 | 0.070 |
Why?
| | Principal Component Analysis | 2 | 2017 | 179 | 0.070 |
Why?
| | Fentanyl | 1 | 2007 | 70 | 0.070 |
Why?
| | Aggression | 1 | 2008 | 184 | 0.070 |
Why?
| | Internet | 1 | 2011 | 602 | 0.070 |
Why?
| | Avoidance Learning | 2 | 2022 | 64 | 0.070 |
Why?
| | Prospective Studies | 2 | 2016 | 6443 | 0.070 |
Why?
| | Models, Biological | 1 | 2014 | 1701 | 0.070 |
Why?
| | Neocortex | 1 | 2006 | 25 | 0.070 |
Why?
| | Neurobiology | 1 | 2005 | 18 | 0.070 |
Why?
| | Radiography | 3 | 2013 | 860 | 0.070 |
Why?
| | Lasers | 1 | 2006 | 124 | 0.070 |
Why?
| | Logic | 1 | 2005 | 6 | 0.070 |
Why?
| | Saccades | 1 | 2005 | 51 | 0.070 |
Why?
| | Mathematical Computing | 1 | 2005 | 13 | 0.070 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 72 | 0.070 |
Why?
| | Discrimination Learning | 1 | 2004 | 49 | 0.060 |
Why?
| | Orientation | 1 | 2004 | 41 | 0.060 |
Why?
| | Memory | 1 | 2006 | 230 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2008 | 545 | 0.060 |
Why?
| | Electroshock | 1 | 2004 | 150 | 0.060 |
Why?
| | Recruitment, Neurophysiological | 2 | 2014 | 35 | 0.060 |
Why?
| | Verbal Learning | 1 | 2003 | 73 | 0.060 |
Why?
| | Self-Assessment | 1 | 2023 | 63 | 0.060 |
Why?
| | Fourier Analysis | 1 | 2003 | 41 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2011 | 1288 | 0.050 |
Why?
| | Poisson Distribution | 2 | 2014 | 68 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 123 | 0.050 |
Why?
| | Cholecystokinin | 1 | 2021 | 15 | 0.050 |
Why?
| | Calibration | 1 | 2022 | 134 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2023 | 210 | 0.050 |
Why?
| | Rats, Long-Evans | 1 | 2021 | 105 | 0.050 |
Why?
| | Aversive Agents | 1 | 2021 | 2 | 0.050 |
Why?
| | Facial Pain | 1 | 2021 | 12 | 0.050 |
Why?
| | Capsaicin | 1 | 2021 | 26 | 0.050 |
Why?
| | Fatigue | 1 | 2022 | 293 | 0.050 |
Why?
| | Interferon Type I | 1 | 2021 | 129 | 0.050 |
Why?
| | Antigens, CD1 | 1 | 2020 | 59 | 0.050 |
Why?
| | Clinical Trials as Topic | 2 | 2018 | 964 | 0.050 |
Why?
| | Mice | 3 | 2021 | 15446 | 0.050 |
Why?
| | Dyspnea | 1 | 2021 | 201 | 0.050 |
Why?
| | Neostriatum | 1 | 2020 | 30 | 0.050 |
Why?
| | Optogenetics | 1 | 2021 | 96 | 0.050 |
Why?
| | Skin Cream | 1 | 2019 | 7 | 0.050 |
Why?
| | Weight Gain | 1 | 2023 | 485 | 0.050 |
Why?
| | Anisotropy | 1 | 2019 | 65 | 0.040 |
Why?
| | Education | 1 | 2020 | 104 | 0.040 |
Why?
| | Headache | 1 | 2020 | 128 | 0.040 |
Why?
| | Diffusion Tensor Imaging | 1 | 2019 | 73 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 343 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2023 | 609 | 0.040 |
Why?
| | Informatics | 1 | 2018 | 9 | 0.040 |
Why?
| | Cell Lineage | 1 | 2020 | 316 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2021 | 380 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 453 | 0.040 |
Why?
| | Taste | 1 | 2021 | 218 | 0.040 |
Why?
| | Neuroimmunomodulation | 1 | 2018 | 71 | 0.040 |
Why?
| | Electroencephalography | 1 | 2020 | 387 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 344 | 0.040 |
Why?
| | Discriminant Analysis | 1 | 2017 | 40 | 0.040 |
Why?
| | Monocytes | 1 | 2020 | 511 | 0.040 |
Why?
| | Motor Activity | 2 | 2017 | 664 | 0.040 |
Why?
| | Proteomics | 1 | 2023 | 850 | 0.040 |
Why?
| | Stochastic Processes | 1 | 2017 | 66 | 0.040 |
Why?
| | Cell Membrane | 1 | 2020 | 700 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2012 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 6541 | 0.030 |
Why?
| | Prisoners | 1 | 2018 | 128 | 0.030 |
Why?
| | Pharmacogenomic Testing | 1 | 2016 | 54 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 246 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2664 | 0.030 |
Why?
| | Autistic Disorder | 1 | 2017 | 166 | 0.030 |
Why?
| | Occipital Lobe | 1 | 2014 | 23 | 0.030 |
Why?
| | Antiparkinson Agents | 1 | 2014 | 26 | 0.030 |
Why?
| | September 11 Terrorist Attacks | 1 | 2014 | 22 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 2837 | 0.030 |
Why?
| | RNA | 1 | 2020 | 830 | 0.030 |
Why?
| | Probability Learning | 1 | 2013 | 2 | 0.030 |
Why?
| | Risk Factors | 2 | 2018 | 8958 | 0.030 |
Why?
| | Impulsive Behavior | 1 | 2015 | 105 | 0.030 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2015 | 239 | 0.030 |
Why?
| | PubMed | 1 | 2013 | 11 | 0.030 |
Why?
| | Macrophages | 1 | 2020 | 1311 | 0.030 |
Why?
| | Genetic Markers | 1 | 2014 | 347 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2491 | 0.030 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 415 | 0.030 |
Why?
| | Psychometrics | 1 | 2016 | 625 | 0.030 |
Why?
| | Rats | 1 | 2021 | 5339 | 0.030 |
Why?
| | Comorbidity | 1 | 2016 | 1516 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2014 | 353 | 0.030 |
Why?
| | Alleles | 1 | 2014 | 829 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2016 | 1683 | 0.030 |
Why?
| | Cohort Studies | 1 | 2021 | 5078 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2435 | 0.020 |
Why?
| | Psychophysics | 1 | 2010 | 17 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2990 | 0.020 |
Why?
| | Obesity | 1 | 2023 | 2715 | 0.020 |
Why?
| | Psychological Tests | 1 | 2010 | 127 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4522 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5230 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 2937 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1405 | 0.020 |
Why?
| | Probability | 1 | 2009 | 302 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2011 | 261 | 0.020 |
Why?
| | Personality Inventory | 1 | 2008 | 134 | 0.020 |
Why?
| | Cortical Synchronization | 1 | 2007 | 12 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2009 | 186 | 0.020 |
Why?
| | Gastrointestinal Tract | 1 | 2009 | 174 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2659 | 0.020 |
Why?
| | Social Control, Informal | 1 | 2005 | 19 | 0.020 |
Why?
| | Form Perception | 1 | 2004 | 12 | 0.020 |
Why?
| | Child, Preschool | 1 | 2017 | 9448 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2009 | 1795 | 0.010 |
Why?
|
|
Wager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|